Filtered By:
Drug: Dexamethasone
Countries: Canada Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 188 results found since Jan 2013.
Production and certification of BOTS-1: bovine muscle-certified reference material for incurred veterinary drug residues
Anal Bioanal Chem. 2023 Jun 16. doi: 10.1007/s00216-023-04794-5. Online ahead of print.ABSTRACTA freeze-dried bovine muscle-certified reference material (CRM), known as BOTS-1 (DOI: https://doi.org/10.4224/crm.2018.bots-1 ), containing incurred residues of commonly used veterinary drugs was produced and certified for the mass fraction of eight veterinary drug residues. Value assignment was carried out using liquid chromatography tandem mass spectrometry (LC-MS/MS) methods in conjunction with isotope dilution and standard addition approaches involving stable isotope internal standards. Data from the National Research Counci...
Source: Analytical and Bioanalytical Chemistry - June 16, 2023 Category: Chemistry Authors: Garnet McRae Donald M Leek Juris Meija Bryn Shurmer Steven J Lehotay Joachim Polzer Jeremy E Melanson Zoltan Mester Source Type: research
Accidental intralenticular injection of a dexamethasone implant in an adult male
Can J Ophthalmol. 2023 May 22:S0008-4182(23)00161-8. doi: 10.1016/j.jcjo.2023.05.001. Online ahead of print.NO ABSTRACTPMID:37230153 | DOI:10.1016/j.jcjo.2023.05.001
Source: Canadian Journal of Ophthalmology - May 25, 2023 Category: Opthalmology Authors: Mitchell D Thatcher Adam M Wandzura Lindsay Ong-Tone Source Type: research
Real-world Outcomes With Cumulative Bortezomib Dose and Efficacy in the Treatment of Transplant-ineligible Multiple Myeloma With Cyclophosphamide, Bortezomib, and Dexamethasone
CONCLUSION: Higher cumulative bortezomib dose showed a lower rate of discontinuation, longer survival, and deeper response. Determining risk of treatment intolerance remains important for treatment.PMID:36396582 | DOI:10.1016/j.clml.2022.10.005
Source: Clinical Lymphoma and Myeloma - November 17, 2022 Category: Cancer & Oncology Authors: Chunpeng Nie Holly Lee Jason Tay Peter Duggan Sylvia McCulloch Paola Neri Nizar J Bahlis Victor H Jimenez-Zepeda Source Type: research
Characteristics, treatment and delirium incidence of older adults hospitalized with COVID-19: a multicentre retrospective cohort study
The objective of the present study was to describe patient characteristics, treatments and outcomes among older adults hospitalized with COVID-19, with a focus on dexamethasone use and delirium incidence.METHODS: We completed this retrospective cohort study at 7 sites (including acute care, rehabilitation and long-term care settings) in Toronto, Ontario, Canada. We included adults aged 65 years or older, consecutively hospitalized with confirmed SARS-CoV-2 infection, between Mar. 11, 2020, and Apr. 30, 2021. We abstracted patient characteristics and outcomes from charts and analyzed them descriptively. We used a logistic r...
Source: cmaj - July 26, 2022 Category: General Medicine Authors: Eric Kai-Chung Wong Jennifer Watt Hanyan Zou Arthana Chandraraj Alissa Wenyue Zhang Jahnel Brookes Ashley Verduyn Anna Berall Richard Norman Katrina Lynn Piggott Terumi Izukawa Sharon E Straus Barbara Liu Source Type: research
Dexamethasone prescribing for cancer pain between palliative care and radiation oncology
CONCLUSION: These findings show that dexamethasone prescriptions are habit-based and that prescribing habits are different between palliative care physicians and radiation oncologists. Interventions based on these findings could potentially prevent unequal patient care. Further qualitative investigations of physician perceptions are indicated to better understand habit-based corticosteroid prescribing patterns.PMID:35689675 | DOI:10.1007/s00520-022-07203-2
Source: Pain Physician - June 11, 2022 Category: Anesthesiology Authors: Andrew Jeong Kevin Wade Source Type: research
Diagnostic evaluation of insulin and glucose dynamics in light-breed horses receiving dexamethasone
CONCLUSION: Dexamethasone administration at 0.08 mg/kg, PO, q24h for 7 d worsened insulin dysregulation in adult light-breed horses based on findings of a basal insulin, OST, CGIT, and insulin sensitivity proxy measurements. There was none to moderate agreement between the basal insulin, OST, CGIT for the diagnosis of insulin dysregulation.CLINICAL RELEVANCE: Horses administered dexamethasone at a dose of 0.08 mg/kg, PO, q24h for 7 d should be considered insulin dysregulation and appropriate preventative strategies should be implemented. The variability of diagnostic performance of common tests for insulin dysregulation (b...
Source: The Canadian Veterinary Journal - June 3, 2022 Category: Veterinary Research Authors: Kathryn J Timko Laura D Hostnik Mauria R Watts Chiaming Chen Adam Bercz Ramiro E Toribio James K Belknap Teresa A Burns Source Type: research
